Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Clinical and Experimental Immunology
|
August 2, 2006
Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients
M Veltkamp, J C Grutters, C H M van Moorsel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
March 1, 1997
Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile?
M Drent, J C Grutters, P G Mulder, et al.
Clinical and Experimental Immunology
|
April 8, 2015
Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis
L Ten Klooster, C H M van Moorsel, J M Kwakkel-van Erp, et al.
Respiratory Medicine
|
December 13, 2017
Clubbing in patients with fibrotic interstitial lung diseases
M J G van Manen, L C Vermeer, C C Moor, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
October 23, 2020
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series
H Mathijssen, M P Huitema, A L M Bakker, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
February 16, 2011
CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases
A Kruit, W B M Gerritsen, N Pot, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 24, 2023
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial
H Adams, E M W van de Garde, D J Vugts, et al.
Respiratory Medicine
|
February 12, 2022
The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD
M G J P Platenburg, J J van der Vis, K M Kazemier, et al.
Lung
|
October 29, 2021
Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis
T W Hoffman, C H M van Moorsel, K M Kazemier, et al.
Respiratory Medicine
|
March 1, 2022
Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screening
M P Huitema, H Mathijssen, A L M Bakker, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Clinical and Experimental Immunology
|
August 2, 2006
Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients
M Veltkamp, J C Grutters, C H M van Moorsel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
March 1, 1997
Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile?
M Drent, J C Grutters, P G Mulder, et al.
Clinical and Experimental Immunology
|
April 8, 2015
Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis
L Ten Klooster, C H M van Moorsel, J M Kwakkel-van Erp, et al.
Respiratory Medicine
|
December 13, 2017
Clubbing in patients with fibrotic interstitial lung diseases
M J G van Manen, L C Vermeer, C C Moor, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
October 23, 2020
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series
H Mathijssen, M P Huitema, A L M Bakker, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
February 16, 2011
CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases
A Kruit, W B M Gerritsen, N Pot, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 24, 2023
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial
H Adams, E M W van de Garde, D J Vugts, et al.
Respiratory Medicine
|
February 12, 2022
The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD
M G J P Platenburg, J J van der Vis, K M Kazemier, et al.
Lung
|
October 29, 2021
Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis
T W Hoffman, C H M van Moorsel, K M Kazemier, et al.
Respiratory Medicine
|
March 1, 2022
Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screening
M P Huitema, H Mathijssen, A L M Bakker, et al.
Page
of 8